Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes

Arch G. Mainous, Vanessa A. Diaz, Dana E. King, Charles J. Everett and Marty S. Player
The Journal of the American Board of Family Medicine November 2008, 21 (6) 497-503; DOI: https://doi.org/10.3122/jabfm.2008.06.080047
Arch G. Mainous III
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa A. Diaz
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana E. King
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles J. Everett
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marty S. Player
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. ↵
    Bock G, Chittilapilly E, Basu R, et al. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increase rates of gluconeogenesis. Diabetes 2007: 7: 1703–11.
    OpenUrl
  2. ↵
    Bookman ID, Pham J, Guindi M, Heathcote EJ. Distinguishing nonalcoholic statohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. Liver Int 2006; 26: 566–71.
    OpenUrlCrossRefPubMed
  3. ↵
    Kawaguchi T, Ide T, Taniguchi E, et al. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 2007; 102: 570–6.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Nannipieri M, Gonzales C, Baldi S, et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 2005; 28: 1757–62.
    OpenUrlAbstract/FREE Full Text
  5. Hanley AJ, Williams K, Festa A, et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2004; 53: 2623–32.
    OpenUrlAbstract/FREE Full Text
  6. Doi Y, Kubo M, Yonemoto K, et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity 2007; 15: 1841–50.
    OpenUrlCrossRefPubMed
  7. Monami M, Bardini G, Lamanna C, et al. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 2008; 57: 387–92.
    OpenUrlCrossRefPubMedWeb of Science
  8. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 2005; 28: 2913–8.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Haffner SM. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity 2006; 14 Suppl 3: 121S–7S.
    OpenUrlCrossRef
  10. ↵
    World Health Organization. Report of a World Health Organization and International Diabetes Federation meeting: screening for type 2 diabetes. Geneva: World Health Organization; 2003.
  11. ↵
    Centers for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults—United States, 1999–2000. MMWR Morb Mortal Wkly Rep 2003; 52: 833–7.
    OpenUrlPubMed
  12. ↵
    Koopman RJ, Mainous AG III, Liszka HA, et al. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med 2006; 4: 427–32.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Glümer C, Carstensen B, Sandbæk A, Lauritzen T, Jørgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004; 27: 727–33.
    OpenUrlAbstract/FREE Full Text
  14. Franciosi M, De Berardis G, Rossi MCE, et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance. Diabetes Care 2005; 28: 1187–94.
    OpenUrlAbstract/FREE Full Text
  15. Thomas C, Hyppönen E, Power C. Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med 2006; 166: 682–8.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    American Diabetes Association. Standards of medical care in diabetes, 2007. Diabetes Care 2007; 30: S4–S41.
    OpenUrlFREE Full Text
  17. ↵
    American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004; 27: S11–S14.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Rockville (MD): Agency for Healthcare Research and Quality; 2008 June. Publication No. 08-05116-EF-2. Available from http://www.ahrq.gov/clinic/uspstf08/type2/type2rs.htm. Accessed 2 September 2008.
  19. ↵
    Diabetes UK. Position Statement: early identification of people with type 2 diabetes. London: Diabetes UK; 2006.
  20. ↵
    National Center for Health Statistics, Centers for Disease Control. National Health and Nutrition Examination Survey. Data Sets and Related Documentation. Available from http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm. Accessed December 2007.
  21. ↵
    National Institute for Alcohol Abuse and Alcoholism. Clinicians Guide 2005. Available from http://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/clinicians_guide.htm. Accessed 12 December 2007.
  22. ↵
    Pearson TA, Mensah GA, Alexander RW, et al. AHA/CDC Scientific Statement. Markers of inflammation and cardiovascular disease. Circulation 2003; 107: 499–511.
    OpenUrl
  23. ↵
    Sudman S, Warnecke R, Johnson T, O'Rourke D, Davis AM. Cognitive aspects of reporting cancer prevention examination and tests. Vital Health Stat, series 6, number 7. Washington DC: National Center for Health Statistics; 1994.
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Medicine: 21 (6)
The Journal of the American Board of Family Medicine
Vol. 21, Issue 6
November-December 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes
Arch G. Mainous, Vanessa A. Diaz, Dana E. King, Charles J. Everett, Marty S. Player
The Journal of the American Board of Family Medicine Nov 2008, 21 (6) 497-503; DOI: 10.3122/jabfm.2008.06.080047

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes
Arch G. Mainous, Vanessa A. Diaz, Dana E. King, Charles J. Everett, Marty S. Player
The Journal of the American Board of Family Medicine Nov 2008, 21 (6) 497-503; DOI: 10.3122/jabfm.2008.06.080047
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • The Gordian Knot of Chronic Illness Care
  • Correction to “The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes”
  • PubMed
  • Google Scholar

Cited By...

  • Association of liver enzymes levels with fasting plasma glucose levels in Southern China: a cross-sectional study
  • Elevated Liver Function Enzymes Are Related to the Development of Prediabetes and Type 2 Diabetes in Younger Adults: The Bogalusa Heart Study
  • Relationships between Alanine Aminotransferase Levels, Abnormal Liver Echogenicity, and Metabolic Syndrome
  • In this Issue: Testing Characteristics of Patient-Centered Medical Homes, Patient Self-Care, Predicting Outcomes, and Practical Clinical Information
  • Re: The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes
  • Optimism: A Good Theme for Family Medicine
  • Chronic Disease: Increasing Prevalence Yet Better Control
  • The Gordian Knot of Chronic Illness Care
  • Google Scholar

More in this TOC Section

  • Associations Between Modifiable Preconception Care Indicators and Pregnancy Outcomes
  • Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
  • Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool
Show more Original Research

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire